|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/402 | |
| A61K 31/404 | |||
| A61K 31/4178 | |||
| A61K 31/4418 | |||
| A61K 31/4439 | |||
| A61K 31/47 | |||
| A61K 31/472 | |||
| A61K 31/496 | |||
| A61P 35/00 |
| (11) | Number of the document | 3160463 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15733926.8 |
| Date of filing the European patent application | 2015-06-25 | |
| (97) | Date of publication of the European application | 2017-05-03 |
| (45) | Date of publication and mention of the grant of the patent | 2020-10-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2015/054792 |
| Date | 2015-06-25 |
| (87) | Number | WO 2015/198266 |
| Date | 2015-12-30 |
| (30) | Number | Date | Country code |
| 201462017406 P | 2014-06-26 | US |
| (72) |
FERRETTI, Stephane, CH
JEAY, Sebastien, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | INTERMITTENT DOSING OF MDM2 INHIBITOR |
| INTERMITTENT DOSING OF MDM2 INHIBITOR |